Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alimena

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Cancer Genetics and Cytogenetics|July 15, 1989
Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapseO M Garson, A Hagemeijer, M Sakurai, et al.
Leukemia|April 24, 1999
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapyC Girmenia, R Latagliata, S Tosti, et al.
Haematologica|December 1, 1981
Combination chemotherapy of unfavourable prognosis non-Hodgkin's lymphomas (NHL). A retrospective study of 53 casesF Mandelli, C Biagini, C D Baroni, et al.
Blood|February 1, 1986
Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemiaC D Bloomfield, A I Goldman, G Alimena, et al.
Haematologica|September 8, 1999
Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unitC Girmenia, G Alimena, R Latagliata, et al.
Cancer Genetics and Cytogenetics|March 1, 1994
Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in LeukemiaG J Swansbury, S D Lawler, G Alimena, et al.
Leukemia|March 17, 2000
Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patientsM Mancini, M Cedrone, D Diverio, et al.
Annals of Hematology|July 2, 2003
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemiasM C Petti, A Tafuri, R Latagliata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2005
Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moonR Latagliata, V Bongarzoni, I Carmosino, et al.
Cancer Genetics and Cytogenetics|July 15, 1989
The clinical significance of karyotype in acute myelogenous leukemiaD C Arthur, R Berger, H M Golomb, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Cancer Genetics and Cytogenetics|July 15, 1989
Cytogenetic studies of 103 patients with acute myelogenous leukemia in relapseO M Garson, A Hagemeijer, M Sakurai, et al.
Leukemia|April 24, 1999
Outpatient management of acute promyelocytic leukemia after consolidation chemotherapyC Girmenia, R Latagliata, S Tosti, et al.
Haematologica|December 1, 1981
Combination chemotherapy of unfavourable prognosis non-Hodgkin's lymphomas (NHL). A retrospective study of 53 casesF Mandelli, C Biagini, C D Baroni, et al.
Blood|February 1, 1986
Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemiaC D Bloomfield, A I Goldman, G Alimena, et al.
Haematologica|September 8, 1999
Out-patient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unitC Girmenia, G Alimena, R Latagliata, et al.
Cancer Genetics and Cytogenetics|March 1, 1994
Long-term survival in acute myelogenous leukemia: a second follow-up of the Fourth International Workshop on Chromosomes in LeukemiaG J Swansbury, S D Lawler, G Alimena, et al.
Leukemia|March 17, 2000
Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patientsM Mancini, M Cedrone, D Diverio, et al.
Annals of Hematology|July 2, 2003
High-dose hydroxyurea in the treatment of poor-risk myeloid leukemiasM C Petti, A Tafuri, R Latagliata, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 2005
Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moonR Latagliata, V Bongarzoni, I Carmosino, et al.
Cancer Genetics and Cytogenetics|July 15, 1989
The clinical significance of karyotype in acute myelogenous leukemiaD C Arthur, R Berger, H M Golomb, et al.
Pageof 14